Does FOSAMPRENAVIR Cause Dyslipidaemia? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Dyslipidaemia have been filed in association with FOSAMPRENAVIR (Fosamprenavir Calcium). This represents 2.4% of all adverse event reports for FOSAMPRENAVIR.
11
Reports of Dyslipidaemia with FOSAMPRENAVIR
2.4%
of all FOSAMPRENAVIR reports
0
Deaths
0
Hospitalizations
How Dangerous Is Dyslipidaemia From FOSAMPRENAVIR?
Of the 11 reports, and 2 (18.2%) were considered life-threatening.
Is Dyslipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FOSAMPRENAVIR. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does FOSAMPRENAVIR Cause?
Viral mutation identified (42)
Virologic failure (39)
Drug resistance (38)
Foetal exposure during pregnancy (38)
Drug interaction (33)
Vomiting (25)
Anaemia (24)
Pathogen resistance (23)
Diarrhoea (22)
Treatment failure (21)
What Other Drugs Cause Dyslipidaemia?
OLANZAPINE (230)
ROSUVASTATIN (206)
ARIPIPRAZOLE (185)
METHOTREXATE (175)
QUETIAPINE (161)
ATORVASTATIN (155)
RISPERIDONE (154)
METFORMIN (151)
TACROLIMUS (149)
ZIPRASIDONE (149)
Which FOSAMPRENAVIR Alternatives Have Lower Dyslipidaemia Risk?
FOSAMPRENAVIR vs FOSAPREPITANT
FOSAMPRENAVIR vs FOSAPREPITANT DIMEGLUMINE
FOSAMPRENAVIR vs FOSCARBIDOPA\FOSLEVODOPA
FOSAMPRENAVIR vs FOSCARNET
FOSAMPRENAVIR vs FOSFOMYCIN